My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Rosiglitazone for treatment of HIV lipodystrophy.

    Mikhail N.

    Ann Intern Med. 2004 Nov 2;141(9):739; author reply 739-40. No abstract available. PMID: 15520438 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patients.

    Hadigan C, Mazza S, Crum D, Grinspoon S.

    AIDS. 2007 Nov 30;21(18):2543-6.PMID: 18025896 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome.

    Feldt T, Oette M, Kroidl A, Goebels K, Fritzen R, Kambergs J, Kappert G, Vogt C, Wettstein M, Häussinger D.

    Infection. 2006 Apr;34(2):55-61.PMID: 16703293 [PubMed - indexed for MEDLINE]Related articles

    4.

    Summaries for patients. Rosiglitazone treatment for fat redistribution and metabolic abnormalities caused by anti-HIV therapy.

    [No authors listed]

    Ann Intern Med. 2004 May 18;140(10):I36. No abstract available. PMID: 15148089 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

    Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S.

    J Infect Dis. 2007 Jun 15;195(12):1754-61. Epub 2007 May 2.PMID: 17492590 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients.

    Oette M, Kurowski M, Feldt T, Kroidl A, Sagir A, Vogt C, Wettstein M, Häussinger D.

    J Antimicrob Chemother. 2005 Aug;56(2):416-9. Epub 2005 Jun 27.PMID: 15983027 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pharmacologic therapy for HIV-associated lipodystrophy.

    Benavides S, Nahata MC.

    Ann Pharmacother. 2004 Mar;38(3):448-57. Epub 2004 Jan 30. Review.PMID: 14755064 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).

    Slama L, Lanoy E, Valantin MA, Bastard JP, Chermak A, Boutekatjirt A, William-Faltaos D, Billaud E, Molina JM, Capeau J, Costagliola D, Rozenbaum W.

    Antivir Ther. 2008;13(1):67-76.PMID: 18389900 [PubMed - indexed for MEDLINE]Related articles

    9.

    Managing HIV lipoatrophy.

    Moyle G, Sutinen J.

    Lancet. 2004 Feb 7;363(9407):412-4. Review. No abstract available. PMID: 14962517 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rosiglitazone for HIV-1 lipoatrophy.

    Cavalcanti RB, Raboud J, Kain KC, Walmsley S.

    Lancet. 2004 May 29;363(9423):1828-9; author reply 1829. No abstract available. PMID: 15172791 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy.

    Calmy A, Hirschel B, Hans D, Karsegard VL, Meier CA.

    AIDS. 2003 Mar 28;17(5):770-2. No abstract available. PMID: 12646807 [PubMed - indexed for MEDLINE]Related articles

    12.

    Combination therapy with fenofibrate and rosiglitazone paradoxically lowers serum HDL cholesterol.

    Normén L, Frohlich J, Montaner J, Harris M, Elliott T, Bondy G.

    Diabetes Care. 2004 Sep;27(9):2241-2. No abstract available. PMID: 15333491 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone.

    Macallan DC, Baldwin C, Mandalia S, Pandol-Kaljevic V, Higgins N, Grundy A, Moyle GJ.

    HIV Clin Trials. 2008 Jul-Aug;9(4):254-68.PMID: 18753120 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Metformin increases HDL3-cholesterol and decreases subcutaneous truncal fat in nondiabetic patients with HIV-associated lipodystrophy.

    Diehl LA, Fabris BA, Barbosa DS, De Faria EC, Wiechmann SL, Carrilho AJ.

    AIDS Patient Care STDS. 2008 Oct;22(10):779-86.PMID: 18800870 [PubMed - indexed for MEDLINE]Related articles

    15.

    Complications & side effects. Disappointing result for rosiglitazone and lipodystrophy.

    [No authors listed]

    TreatmentUpdate. 2004 Mar;16(2):7. No abstract available. PMID: 17219670 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids improves body composition and lipid profile in a patient with human immunodeficiency virus lipodystrophy]

    Vázquez C, Reyes R, Alcaraz F, Balsa JA, Botella-Carretero JI.

    Nutr Hosp. 2006 Jul-Aug;21(4):552-5. Spanish. PMID: 16913216 [PubMed - indexed for MEDLINE]Related articles

    17.

    Thiazolidinediones and lowered HDL cholesterol.

    Savage RL, Kiuru A.

    Diabetes Care. 2005 Sep;28(9):2329-30. No abstract available. PMID: 16123514 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Limb fat wasting improves with rosiglitazone therapy.

    [No authors listed]

    Proj Inf Perspect. 2009 Mar;(48):14. No abstract available. PMID: 19492465 [PubMed - indexed for MEDLINE]Related articles

    19.

    Summaries for patients. HIV lipodystrophy: rosiglitazone or metformin?

    [No authors listed]

    Ann Intern Med. 2005 Sep 6;143(5):I38. No abstract available. PMID: 16144888 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment.

    Shetty C, Balasubramani M, Capps N, Milles J, Ramachandran S.

    Diabet Med. 2007 Jan;24(1):94-7.PMID: 17227331 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity